|
|
|||||
|
|
|
||||
|
January 2008 ATLANTA Male circumcision had no significant effect on HIV prevalence in a U.S. population of men who have sex with men, according to a recent study. These results were in contrast to recent findings in three trials in Africa indicating that male circumcision could help reduce the risk of heterosexually-acquired HIV among men. Researchers estimated a 60% reduction in HIV risk for circumcised men based on results from these African trials. The trials closed early due to clear efficacy and UNAIDS and WHO began recommending male circumcision as an added method to help prevent the spread of female to male HIV transmission. But new evidence from studies conducted in the United States, Peru and Australia indicate that male circumcision may not be universally associated with a significant reduction in HIV transmission. However, the patient populations in the African trials were overwhelmingly heterosexual. The recent studies in the United States, Peru and Australia examined men who have sex with men (MSM). There are several key differences in the African trials and in the United States that we have to keep in mind when considering implications for the U.S. population, said Peter H. Kilmarx, MD, chief of the epidemiology branch in the division of HIV/AIDS prevention at CDC. Findings from the African trials may not necessarily be transferred to the U.S. population for several reasons, Kilmarx said. Major differences in transmission modes, overall HIV prevalence and circumcision rates among adult men in the United States may decrease the impact of circumcision as HIV prevention. Kilmarx presented an overview on male circumcision and HIV at the 2007 National HIV Prevention Conference, held here recently.
|
![]()